The market is segmented based on , By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), Fungi Type (Dermatophytes, Yeasts, Molds, Others), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
.
The Global Mycoses Treatment Market size was valued at USD 431.68 USD Million in 2021.
The Global Mycoses Treatment Market is projected to grow at a CAGR of 8% during the forecast period of 2022 to 2029.
The major players operating in the market include Novartis, Endo International, Teva Pharmaceutical Industries, Glenmark Pharmaceuticals, Cipla, Dr Reddy's Laboratories, Abbott, F. Hoffmann La Roche, Pfizer, Lupin, Vintage Labs, Abbvie, Zydus Group, Wockhardt, Lannett.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.